Dr. Amanda Ricciuto: Long-Term Health Outcomes in IBD Patients with Primary Sclerosing Cholangitis скачать в хорошем качестве

Dr. Amanda Ricciuto: Long-Term Health Outcomes in IBD Patients with Primary Sclerosing Cholangitis

Up to 8% of people with inflammatory bowel disease (IBD) have a liver disease called primary sclerosing cholangitis (PSC). PSC causes inflammation and scarring of the bile ducts. Patients with IBD and PSC (PSC-IBD) are at high risk of end-stage liver disease, colon cancer, and bile duct cancer. PSC is a leading cause of death in IBD populations. Research about IBD complicated by PSC has been limited so far. Dr. Ricciuto’s study aims to examine the long-term health outcomes (cancer, intestinal surgery, liver transplant, and death) and health services utilization (hospitalization, emergency department visits, colonoscopy, and imaging) in patients with PSC-IBD complications in order to inform resource allocation and risk stratification initiatives that include patient counselling. Learn more about Crohn's and Colitis Canada's 2021 Grants-in-Aid of Research recipients at crohnsandcolitis.ca